Biological and Pharmaceutical Bulletin · 2006 · 62 citations · 18 references
MedicineOncologyPharmacologyApoptosisBiochemical PharmacologyCancer PharmacologyApoptosis In CancerApoptosis ModulationApoptosis PharmacologyApoptosis RegulationApoptosis ResistanceOncology PharmacologyAnti-apoptotic AgentsAnticancer ActivityAnticancer Marine CompoundsAnticancer Mechanism Of ActionMarine-derived Anticancer Compounds
We purified a sterol with antitumor activity from the edible mushroom Sarcodon aspratus (BERK.) S. ITO and identified it as 5alpha,8alpha-epidioxy-22E-ergosta-6,9(11),22-trien-3beta-ol (9,11-dehydroergosterol peroxide (9(11)-DHEP)). Purified 9(11)-DHEP was a more effective inhibitor of HL60 leukemia cell growth and stronger apoptosis-inducer than 5alpha,8alpha-epidioxy-22E-ergosta-6,22-dien-3beta-ol (ergosterol peroxide (EP)) that we had previously identified as an apoptosis inducer. Moreover, 9(11)-DHEP selectively suppressed the growth of HT29 human colon adenocarcinoma cells but not WI38 normal human fibroblasts. After 5 d incubation of HT29 with 7 microM 9(11)-DHEP, the number of S phase cells decreased from 23 to 15% of total diploid cells and 17% became hypodiploid. Expression of the cyclin-dependent kinase inhibitor 1A (p21, WAF1, Cip1) (CDKN1A), which has been shown to cause cell cycle arrest and apoptosis in HT29 cells, was induced by 9(11)-DHEP. These results suggest that 9(11)-DHEP inhibits HT29 cell growth by inducing CDKN1A expression, thus causing cell cycle arrest and apoptosis.
18
Antitumor sterols from the mycelia of Cordyceps sinensis
Jin Woo Bok, Leonard Lermer, Jeff Chilton et al. · Phytochemistry · 1999 · 330 citations
Life Sciences, Biochemistry, Botany +14
Shing‐Chuan Shen, Ching Huai Ko, Shi-Wen Tseng et al. · Toxicology and Applied Pharmacology · 2004 · 118 citations
Medicine, Cancer Biology, Oncology +14